Subtype
Benign Bone Neoplasm
CI-CAN-00001868Explore in graph →
Non-malignant3 active trials5 evidence items
- NCIt
- C4880
Loading cancer entity…
Subtype
CI-CAN-00001868Explore in graph →
Clinical trials
32 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03442985 | An Efficacy and Safety Study of Palovarotene for the Treatment of MO(MO-Ped) | terminated | Phase 2 | 193 | Clementia Pharmaceuticals Inc.INDUSTRY | 12 | Aug 1, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Aug 1, 2022source: clinicaltrials